CD274 and neoplasm: Preclinical studies suggested that tumor cells in mantle cell lymphoma (MCL) can evade the immune antitumor response by several microenvironmental factors, including T cells which are able to inhibit cytokine CD4+CD25− production by interaction between PD-1 and PD-L1.